We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.92%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$31.1B
AUM Growth
+$1.68B
(+5.7%)
Cap. Flow
+$21M
Cap. Flow
% of AUM
0.07%
Top 10 Holdings %
Top 10 Hldgs %
14.12%
Holding
3,080
New
66
Increased
2,426
Reduced
529
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chubb
CB
|
+$39M |
| 2 |
Hewlett Packard
HPE
|
+$35.3M |
| 3 |
Synchrony
SYF
|
+$29.5M |
| 4 |
Comcast
CMCSA
|
+$25.4M |
| 5 |
Illumina
ILMN
|
+$13.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CB
CHUBB CORPORATION
CB
|
+$43M |
| 2 |
HP
HPQ
|
+$38.8M |
| 3 |
CMCSK
COMCAST CORP SPL A (NEW)
CMCSK
|
+$25.8M |
| 4 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$22.9M |
| 5 |
ALTR
Altera Corp
ALTR
|
+$21.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.31% |
| 2 | Healthcare | 14.62% |
| 3 | Technology | 14.1% |
| 4 | Industrials | 10.66% |
| 5 | Consumer Discretionary | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OSIR
2801
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $199K | ﹤0.01% |
19,184
-505
| -3% | -$6.85K |
|
|
HMTV
2802
DELISTED
Hemisphere Media Group, Inc.
HMTV
| $198K | ﹤0.01% |
13,420
+460
| +4% | +$6.43K |
|
|
ALR
2803
DELISTED
AlerisLife Inc
ALR
| $197K | ﹤0.01% |
6,183
+224
| +4% | +$7.54K |
|
|
SZYM
2804
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
| $197K | ﹤0.01% |
79,615
+7,525
| +10% | +$22.3K |
|
2805
Alto Ingredients
ALTO
$397M
| $196K | ﹤0.01% |
40,970
+3,145
| +8% | +$16.4K |
|
|
ZVO
2806
DELISTED
Zovio Inc. Common Stock
ZVO
| $196K | ﹤0.01% |
25,799
+495
| +2% | +$3.95K |
|
|
MCF
2807
DELISTED
Contango Oil & Gas Co.
MCF
| $196K | ﹤0.01% |
30,531
+3,815
| +14% | +$30K |
|
2808
Covenant Logistics
CVLG
$908M
| $195K | ﹤0.01% |
+20,594
| New | +$203K |
|
|
OREX
2809
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $195K | ﹤0.01% |
11,366
+1,885
| +20% | +$44.9K |
|
2810
Lifetime Brands
LCUT
$201M
| $194K | ﹤0.01% |
14,634
+605
| +4% | +$8.51K |
|
|
CUTR
2811
DELISTED
Cutera, Inc.
CUTR
| $194K | ﹤0.01% |
15,176
+2,800
| +23% | +$37.9K |
|
|
CTRL
2812
DELISTED
Control4 Corporation
CTRL
| $194K | ﹤0.01% |
26,739
+1,115
| +4% | +$8.52K |
|
2813
TechTarget
TTGT
$309M
| $192K | ﹤0.01% |
23,903
+1,225
| +5% | +$10.6K |
|
|
USAK
2814
DELISTED
USA Truck Inc
USAK
| $192K | ﹤0.01% |
11,027
+720
| +7% | +$13.5K |
|
2815
FIVE9
FIVN
$2.27B
| $191K | ﹤0.01% |
21,940
+2,295
| +12% | +$13.3K |
|
|
PFNX
2816
DELISTED
Pfenex Inc.
PFNX
| $190K | ﹤0.01% |
15,309
+1,480
| +11% | +$21.8K |
|
2817
Genie Energy
GNE
$370M
| $186K | ﹤0.01% |
16,655
+980
| +6% | +$11.1K |
|
|
NSTG
2818
DELISTED
NanoString Technologies, Inc.
NSTG
| $186K | ﹤0.01% |
12,662
+1,155
| +10% | +$17K |
|
|
MCRN
2819
DELISTED
Milacron Holdings Corp.
MCRN
| $186K | ﹤0.01% |
+14,895
| New | +$228K |
|
|
DTLK
2820
DELISTED
Datalink Corp
DTLK
| $186K | ﹤0.01% |
27,311
+775
| +3% | +$5.5K |
|
2821
Escalade
ESCA
$305M
| $185K | ﹤0.01% |
14,000
+1,630
| +13% | +$23K |
|
|
JIVE
2822
DELISTED
Jive Software, Inc.
JIVE
| $185K | ﹤0.01% |
45,396
+4,180
| +10% | +$19.7K |
|
|
CPRX
2823
DELISTED
Catalyst Pharmaceutical
CPRX
| $184K | ﹤0.01% |
75,216
+6,710
| +10% | +$19.2K |
|
2824
Tandem Diabetes Care
TNDM
$1.33B
| $184K | ﹤0.01% |
1,562
+158
| +11% | +$15.7K |
|
|
CDMO
2825
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $184K | ﹤0.01% |
22,430
+2,675
| +14% | +$21.6K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2015 Portfolio in Review
As of Q4 2015, RhumbLine Advisers held 3,080 positions worth $31.1B, up 5.7% from $29.4B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Trading was light in Q4 2015: portfolio turnover was 3.6%. RhumbLine Advisers opened 66 new positions and exited 46, leaving the 3,080-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Technology.
- RhumbLine Advisers's largest Q4 2015 buy was Hewlett Packard: 4,220,807 shares worth $37.3M.
- RhumbLine Advisers added most to Chubb in Q4 2015, an estimated $39M increase.
- RhumbLine Advisers's biggest Q4 2015 reduction was HP, cutting an estimated $38.8M.
- RhumbLine Advisers fully exited CHUBB CORPORATION in Q4 2015, selling an estimated $43M.
- RhumbLine Advisers's ten largest holdings make up 14% of its $31.1B portfolio in Q4 2015.
- RhumbLine Advisers opened 66 new positions and closed 46 in Q4 2015.
- RhumbLine Advisers's portfolio value rose 5.7% quarter-over-quarter to $31.1B.
Based on RhumbLine Advisers's 13F filing for Q4 2015, filed 3 Feb 2016.